Perspective: Molecular-Action Pathways for Autism Drug Discovery: Organoids, Circadian Dynamics, and Genetic Engineering
Abstract
This paper outlines an integrated molecular-action framework for ASD drug discovery, combining
human patient-derived cerebral organoids, circadian biology, and targeted genetic and chemical
interventions. It details explicit biochemical sequences for key molecular nodes like clock
transcription factors and synaptic scaffold proteins.
Keywords & Fields
Cite this work (BibTeX)
@article{deceuster2026_45-perspective-molec,
title = {Perspective: Molecular-Action Pathways for Autism Drug Discovery: Organoids, Circadian Dynamics, and Genetic Engineering},
author = {De Ceuster, Peter},
year = {2026},
month = {01},
institution = {SIG Labs},
doi = {10.5281/zenodo.16787215},
url = {https://peterdeceuster.uk/papers/45-perspective-molecular-action-pathways-for-autism-drug-discovery},
note = {Full text available at https://peterdeceuster.uk/articenter/work/perspective (2).pdf}
}